Repeat-insult patch (HRIPT)
What is Repeat-insult patch (HRIPT)?
A repeated human patch-test protocol addressing sensitisation potential.
Why do you need this service?
Use HRIPT only after an appropriate prior safety review to investigate responses under a defined repeated-exposure protocol. Induction, rest and challenge phases distinguish it from a single irritation patch study.
Be the first company on this service page
No published company profiles are linked to Repeat-insult patch (HRIPT) or its more specific services yet. Explore the service categories or add an explicitly supported capability to your company profile.
Human repeat-insult patch testing
HRIPT is a controlled human study designed to investigate sensitisation potential after repeated skin exposure. It is distinct from a single irritation patch test and requires prior safety assessment, ethical oversight and clinical safeguards.
Induction, rest and challenge
During induction, the test product is applied repeatedly under specified patch conditions. A rest period follows before a challenge application, generally at a previously unexposed site, with observations scheduled to detect delayed responses.
- Defined induction application schedule and exposure conditions
- A documented rest interval
- Challenge application and follow-up readings
- Clinical grading and review of any reactions
The number of applications, patch duration and reading times depend on the selected protocol. Occlusion changes exposure and should not be described as a direct simulation of everyday cosmetic use.
Irritation observations and interpretation
Clinicians may grade erythema and oedema using a specified scale during the study. These observations help distinguish irritation from reactions requiring further assessment, but interpretation depends on timing, pattern and medical review.
Single-patch and cumulative irritation studies answer related but separate questions. The HRIPT report should identify the tested formula, participant population, completion and withdrawal data, adverse events and clinical conclusions. A study without observed sensitisation supports only a qualified conclusion under its test conditions, not universal hypoallergenicity or automatic regulatory acceptance.
Applications of repeat-insult patch testing
Scoping the study
A qualified study team should assess product suitability, participant eligibility, ethical safeguards and stopping criteria before exposure. The protocol defines repeated induction applications, a rest period and challenge assessment with documented grading. A short single patch or generic few-day screen should not be represented as a complete HRIPT.
Interpreting the report
Findings should identify the tested formulation, exposure conditions, participant completion and any irritation or suspected sensitization responses. Absence of a reaction in the study does not guarantee that no consumer will react. HRIPT is not a first hazard-discovery screen for inadequately characterized raw materials, nor automatic proof of hypoallergenicity or universal regulatory compliance.
Assess cosmetic tolerance in human participants through supervised patch or use studies, with observations and conclusions tied to a defined protocol. Explore another Human Tolerance Testing page on cosmetic-labs.com.